Synonym
                                        FF-106; FF 106; FF106; Butibufen
                                     
                                    
                                        IUPAC/Chemical Name
                                        2-(p-Isobutylphenyl)butyric acid
                                     
                                    
                                        InChi Key
                                        UULSXYSSHHRCQK-UHFFFAOYSA-N
                                     
                                    
                                        InChi Code
                                        InChI=1S/C14H20O2/c1-4-13(14(15)16)12-7-5-11(6-8-12)9-10(2)3/h5-8,10,13H,4,9H2,1-3H3,(H,15,16)
                                     
                                    
                                        SMILES Code
                                        CCC(C1=CC=C(CC(C)C)C=C1)C(O)=O
                                     
                                    
                                    
                                        Purity
                                        >98% (or refer to the Certificate of Analysis)
                                     
                                    
                                        Shipping Condition
                                        Shipped under ambient temperature as non-hazardous chemical.  This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
                                     
                                    
                                        Storage Condition
                                        Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
                                     
                                    
                                        Solubility
                                        Soluble in DMSO
                                     
                                    
                                        Shelf Life
                                        >2 years if stored properly
                                     
                                    
                                        Drug Formulation
                                        This drug may be formulated in DMSO
                                     
                                    
                                        Stock Solution Storage
                                        0 - 4 C for short term (days to weeks), or -20 C for long term (months).
                                     
                                    
                                        HS Tariff Code
                                        2934.99.9001
                                     
                                    
                                        More Info
                                        
                                            
                                                Related CAS#
CAS No.
55837-18-8 (Butibufen )
60682-24-8 (Butibufen Sodium)
                                            
                                         
                                     
                                 
                             
                            
                                                        
                                                                
                                    Preparing Stock Solutions
                                    
                                        The following data is based on the
                                        product
                                        molecular weight
                                        220.31
                                        Batch specific molecular weights may vary
                                        from batch to batch
                                        due to the degree of hydration, which will
                                        affect the solvent
                                        volumes required to prepare stock solutions.
                                    
                                    
                                    
                                        
                                            
                                            
                                                | Concentration / Solvent Volume / Mass | 
                                                1 mg | 
                                                5 mg | 
                                                10 mg | 
                                            
                                            
                                            
                                            
                                                | 1 mM | 
                                                1.15 mL | 
                                                5.76 mL | 
                                                11.51 mL | 
                                            
                                            
                                                | 5 mM | 
                                                0.23 mL | 
                                                1.15 mL | 
                                                2.3 mL | 
                                            
                                            
                                                | 10 mM | 
                                                0.12 mL | 
                                                0.58 mL | 
                                                1.15 mL | 
                                            
                                            
                                                | 50 mM | 
                                                0.02 mL | 
                                                0.12 mL | 
                                                0.23 mL | 
                                            
                                            
                                        
                                     
                                 
                                                             
                            
                            
                                
                                    1: Castell JV, Larrauri A, Gómez-Lechón MJ. A study of the relative hepatotoxicity in vitro of the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and butibufen. Xenobiotica. 1988 Jun;18(6):737-45. doi: 10.3109/00498258809041712. PMID: 3420949.
2: Castell JV, Gómez-Lechón MJ, Miranda MA, Morera IM. Phototoxicity of non- steroidal anti-inflammatory drugs: in vitro testing of the photoproducts of Butibufen and Flurbiprofen. J Photochem Photobiol B. 1992 Apr 15;13(1):71-81. doi: 10.1016/1011-1344(92)80041-s. PMID: 1403370.
3: Hoult JR, Jackson BR, Benicka E, Patel BK, Hutt AJ. Chromatographic resolution, chiroptical characterization and preliminary pharmacological evaluation of the enantiomers of butibufen: a comparison with ibuprofen. J Pharm Pharmacol. 1999 Oct;51(10):1201-5. doi: 10.1211/0022357991776741. PMID: 10579692.
4: del Prado Míguez M, Jordá A, Cabo J. Inhibition of ureogenesis in isolated rat liver cells by a non-steroidal anti-inflammatory drug (butibufen). Biochem Pharmacol. 1986 Jul 1;35(13):2145-8. doi: 10.1016/0006-2952(86)90584-8. PMID: 2873817.
5: Barrigon S, Esteban M, Gallardo J, del Olmo J. Butibufen enteric-coated vs non-enteric-coated microcapsules: pharmacokinetics and gastrointestinal blood loss effect relationships in healthy volunteers. Arch Farmacol Toxicol. 1985 Dec;11(3):189-97. Erratum in: Arch Farmacol Toxicol 1986 Apr;12(1):83. PMID: 3879444.
6: Aparicio L. Some aspects of the pharmacology of butibufen, a non-steroidal anti-inflammatory agent. Arch Int Pharmacodyn Ther. 1977 May;227(1):130-41. PMID: 901061.
7: Alamo C, Ferrándiz B, López-Muñoz F, Alguacil LF. Influence of butibufen on enzyme activity and lysosomal stabilization ex vivo: a comparative study with hydrocortisone and acetylsalicylic acid. Methods Find Exp Clin Pharmacol. 1995 Jun;17(5):303-10. PMID: 8830198.
8: González Tavares L, Pérez de la Cruz MJ, Sanz Saiz P, Camacho MA, Martin JL. High pressure liquid chromatographic determination of the new non-steroidal anti-inflammatory agent butibufen. Arzneimittelforschung. 1992 Jun;42(6):818-20. PMID: 1418037.
9: Kerdesky FA, Brooks CD, Hulkower KI, Bouska JB, Bell RL. Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors. Bioorg Med Chem. 1997 Feb;5(2):393-6. doi: 10.1016/s0968-0896(96)00255-6. PMID: 9061203.
10: Martí-Massó R, Honorato J, Martínez G. Estudio clínico-farmacológico lineal del butibufen en afecciones reumáticas [Lineal clinico-pharmacological study of butibufen in rheumatic diseases]. Rev Med Univ Navarra. 1974 Sep- Dec;18(3-4):165-78. Spanish. PMID: 4620372.
11: Miranda MA, Morera I, Vargas F, Gómez-Lechón MJ, Castell JV. In vitro assessment of the phototoxicity of anti-inflammatory 2-arylpropionic acids. Toxicol In Vitro. 1991;5(5-6):451-5. doi: 10.1016/0887-2333(91)90071-k. PMID: 20732055.
12: Rico H, Alamo C, Revilla M, Villa LF, Alguacil LF. Effect of adjuvant- induced arthritis on bone mass in rats and its prevention by non-steroid anti- inflammatory drugs (NSAIDs). Clin Exp Rheumatol. 1992 Nov-Dec;10(6):595-7. PMID: 1483311.